Life Sciences: Corporate/Commercial
California
1 year ranked
Provided by Paul Hastings LLP
Jeff Hartlin is a partner in the Corporate Department of Paul Hastings and is based in the firm’s Palo Alto and San Diego offices. Jeff concentrates his practice in corporate law, capital-raising, mergers & acquisitions and securities and has represented public and private companies in the software, hardware, information technology, biotechnology/biopharmaceutical, medical device, Web 3.0, semiconductor, clean technology and financial industries. His experience in all aspects of the capital raising process includes representing issuers, underwriters, venture capital firms and placement agents in IPOs, SPAC financings, registered directs, at-the-market offerings and rights offerings, as well as venture and angel-backed private placements, PIPEs, debt financings, Rule 144A transactions, reverse mergers and Regulation S offerings.
Jeff also routinely represents startup and other early-stage companies from incorporation through early financing, pre-IPO capital raising, IPO and eventual sale. Jeff has represented several public and private companies in equity and debt private placements with a combined value of several billion. He also represents Nasdaq and NYSE companies with their periodic reporting requirements and listing qualification issues. He regularly advises boards of directors and management of public and private companies regarding corporate governance issues, including the Sarbanes-Oxley Act, the Dodd-Frank Act and the JOBS Act. Jeff also represents public and private corporations in merger and acquisition transactions, de-SPAC transactions, joint ventures, leveraged and non-leveraged acquisitions, spinoffs, spin-ins and dispositions. He is frequently engaged to advise companies in activist stockholder matters.
University of Virginia School of Law, J.D. (Editor-in-Chief of the Virginia Tax Review)
University of California Davis, B.A. (Phi Beta Kappa)
Provided by Chambers
Jeffrey Hartlin is recognized for his work on deals in the life sciences space. He represents the gamut of clients, ranging from startups to established companies in the pharmaceutical and biotechnology spaces. He has notable experience in M&A and IPO deals.
Jeffrey Hartlin has notable experience advising clients in the biopharmaceutical industry on IPOs and debt offerings, among other issues.
Provided by Chambers
Jeff works on good M&A transactions and is a creative thinker.
Jeffrey is a good attorney and a smart guy.
Jeff is an expert in capital raising in the life sciences sector.
Jeff is an expert in capital raising in the life sciences sector.
Chambers is the leading data and intelligence partner for the legal sector.